Lymphohistiocytosis, Hemophagocytic Recruiting Phase 1 / 2 Trials for Ruxolitinib (DB08877)

Also known as: Hemophagocytic Lymphohistiocytosis / Erythrophagia / Histiocytosis hematophagic / Histiocytosis haematophagic / Haemophagocytosis / Hemophagocytosis / Haemophagocytic lymphohistiocytosis / Familial hemophagocytic reticulosis

IndicationStatusPhase
DBCOND0001493 (Lymphohistiocytosis, Hemophagocytic)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03795909Ruxolitinib Combined With Dexamethasone for HLHTreatment